Cargando…

Policy cooperation and interface issues

Detalles Bibliográficos
Autores principales:	Vogler, Sabine, Zimmermann, Nina, Wirtz, Veronika J, Babar, Zaheer-Ud-Din
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4603337/ http://dx.doi.org/10.1186/2052-3211-8-S1-E3

Ejemplares similares

Policies beyond the crisis: lesson learned
por: Vogler, Sabine, et al.
Publicado: (2015)

Challenges and opportunities for pharmaceutical pricing and reimbursement policies
por: Vogler, Sabine, et al.
Publicado: (2015)

Pharmaceutical policies in a crisis? Challenges and solutions identified at the PPRI Conference
por: Vogler, Sabine, et al.
Publicado: (2016)

The future of medicines use and access research: using the Journal of Pharmaceutical Policy and Practice as a platform for change
por: Babar, Zaheer-Ud-Din, et al.
Publicado: (2014)

Identifying priority medicines policy issues for New Zealand: a general inductive study
por: Babar, Zaheer-Ud-Din, et al.
Publicado: (2014)

Addressing the medicines access challenge through balance, evidence, collaboration and transparency: key take-away lessons of the 4th PPRI Conference
por: Vogler, Sabine, et al.
Publicado: (2021)

Evidence based pharmaceutical policy research: Is it all talk or does it contribute to improving health in developing countries?
por: Babar, Zaheer-Ud-Din, et al.
Publicado: (2010)

Southern Med Review to Journal of Pharmaceutical Policy and Practice: broadening the remit!
por: Babar, Zaheer-Ud-Din, et al.
Publicado: (2013)

Pharmaceutical policies in Australia and New Zealand
por: Babar, Zaheer-Ud-Din
Publicado: (2015)

The Need for an Evidence-Based Encyclopaedia in Health Services Research in Pharmacy
por: Babar, Zaheer-Ud-Din
Publicado: (2020)

Forming a medicines pricing policy for low and middle-income countries (LMICs): the case for Pakistan
por: Babar, Zaheer-Ud-Din
Publicado: (2022)

Mapping the pharmaceutical situation in your country: First things first...
por: Babar, Zaheer-Ud-din, et al.
Publicado: (2009)

Identifying priority medicines policy issues for Qatar: exploring perspectives and experiences of healthcare professionals through a qualitative study
por: Zia, Nadeem, et al.
Publicado: (2021)

Ethnicity, Migration and Minority Groups: Medicines Access and Use in High-Income Economies
por: Scahill, Shane, et al.
Publicado: (2012)

Pharmacy practice: Is the gap between the North and South widening?
por: Babar, Zaheer-Ud-din, et al.
Publicado: (2012)

Medicine and the future of health: reflecting on the past to forge ahead
por: Fisher, Dale, et al.
Publicado: (2016)

Medicine and the future of health: reflecting on the past to forge ahead
por: Fisher, Dale, et al.
Publicado: (2016)

Prices of oncology medicines in European countries, Australia and New Zealand
por: Vogler, Sabine, et al.
Publicado: (2015)

Medicines and universal health coverage: challenges and opportunities
por: Bigdeli, Maryam, et al.
Publicado: (2015)

Pharmacists at the frontline beating the COVID-19 pandemic
por: Bukhari, Nadia, et al.
Publicado: (2020)

Access to Orphan Drugs: A Comprehensive Review of Legislations, Regulations and Policies in 35 Countries
por: Gammie, Todd, et al.
Publicado: (2015)

Consistent defined threshold and equity in health
por: Nikfar, Shekoufeh, et al.
Publicado: (2015)

“Health supply chain personnel: an integral part of the health workforce.”
por: Cometto, Giorgio, et al.
Publicado: (2014)

Access to Medicines and Pharmaceutical Policy in Saudi Arabia: A Scoping Review
por: Mirza, Ahmer Hameed, et al.
Publicado: (2023)

Policy options to deal with high-cost medicines – survey with European policy-makers
por: Zimmermann, Nina, et al.
Publicado: (2015)

Ten recommendations to improve pharmacy practice in low and middle-income countries (LMICs)
por: Babar, Zaheer-Ud-Din
Publicado: (2021)

Using health markets to improve access to medicines: three case studies
por: Shroff, Zubin, et al.
Publicado: (2016)

The effects of pricing policy on the prices and supply of low-cost medicines in Shandong, China: evidence from an interrupted time series analysis
por: Rong, Xuejing, et al.
Publicado: (2020)

Weaving the health and pharmaceutical care agenda through the themes of the commonwealth heads of government meeting (CHOGM), London 2018
por: Rutter, Victoria, et al.
Publicado: (2018)

A Qualitative Study of Stakeholders’ Views on Pharmacovigilance System, Policy, and Coordination in Pakistan
por: Khan, Muhammad Akhtar Abbas, et al.
Publicado: (2022)

Intradural Disc Herniation: A Case Report and Literature Review
por: Ashraf, Almas, et al.
Publicado: (2020)

Marketing authorization of COVID-19 vaccines across UK, EU, and the US: fact-checking and the implications for future research
por: Abbas, Nasir, et al.
Publicado: (2021)

Global landscape of community pharmacy services remuneration: a narrative synthesis of the literature
por: Hussain, Rabia, et al.
Publicado: (2023)

Health care for all: effective, community supported, healthcare with innovative use of telemedicine technology
por: Shah, Tariq Kazim, et al.
Publicado: (2018)

The Pharmaceutical Pricing and Reimbursement Information (PPRI) network – a decade of exchange of information and policy research?
por: Vogler, Sabine, et al.
Publicado: (2015)

Pharmaceutical policies in European countries in response to the global financial crisis
por: Vogler, Sabine, et al.
Publicado: (2011)

Introduction to the Special Issue on Climate Ethics: Uncertainty, Values and Policy
por: Roeser, Sabine
Publicado: (2017)

Preventive measures and management of COVID-19 in pregnancy
por: Omer, Sumaira, et al.
Publicado: (2020)

Drive-thru pharmacy services: A way forward to combat COVID-19 pandemic
por: Hussain, Rabia, et al.
Publicado: (2021)

Recommendations to improve pharmacy practice research in the Middle Eastern Arab countries
por: Obaid, Daneh, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_63btr94bla79blmviin9tgeuir